Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations

Title
Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations
Authors
Keywords
NSCLC, Erlotinib, EGFR, mutations, Uncommon, Rare
Journal
Journal of Thoracic Oncology
Volume 11, Issue 4, Pages 545-555
Publisher
Elsevier BV
Online
2016-01-08
DOI
10.1016/j.jtho.2015.12.107

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now